Kovid 19 Haberleri


        
 
Haber:
Etiketler:
Yazarın adı:
Yazarın soyadı:


17 Kasım 2021, Çarşamba, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021
Nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. A total of 17 thrombotic events with thrombocytopenia were detected, including three non-CVST events.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421539


17 Kasım 2021, Çarşamba, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021
In U.S. hospitals during January-March 2021, receipt of Pfizer-BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% effective among partially vaccinated adults aged ≥65 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421438


17 Kasım 2021, Çarşamba, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021
The Advisory Committee on Immunization Practices concluded that the benefits of resuming Janssen COVID-19 vaccination among persons aged ≥18 years outweighed the risks and reaffirmed its interim recommendation under FDA's Emergency Use Authorization, which includes a new warning for rare clotting events among women aged 18-49 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421416


17 Kasım 2021, Çarşamba, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021
Twenty-two possible breakthrough SARS-CoV-2 infections occurred among fully vaccinated persons ≥14 days after their second dose of COVID-19 vaccine. Two thirds of persons were asymptomatic. A minority of persons with breakthrough infection experienced mild to moderate COVID-19-like symptoms; two COVID-19-related hospitalizations and one death occurred. No facility-associated secondary transmission was identified.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420772


17 Kasım 2021, Çarşamba, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021
In a COVID-19 outbreak at a Kentucky skilled nursing facility involving a newly introduced variant to the region, unvaccinated residents and health care personnel (HCP) had 3.0 and 4.1 times the risk of infection as did vaccinated residents and HCP. Vaccine was 86.5% protective against symptomatic illness among residents and 87.1% protective among HCP.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420773


17 Kasım 2021, Çarşamba, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020
This report describes the interim recommendation made by the Advisory Committee on Immunization Practices on December 19, 2020, for use of the Moderna COVID-19 vaccine in persons aged ≥18 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=415166


17 Kasım 2021, Çarşamba, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Impact of COVID-19 Pandemic on Global Poliovirus Surveillance
This report describes a decline in polio case reporting during the first 9 months of 2020.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=415351


17 Kasım 2021, Çarşamba, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Trends in Racial and Ethnic Disparities in COVID-19 Hospitalizations, by Region - United States, March-December 2020
Within each U.S. Census region, the proportion of hospitalized patients with COVID-19 was highest for Hispanic or Latino patients. Racial and ethnic disparities were largest during May-July 2020 and became less pronounced as the pandemic spread throughout the country; however, disparities remained in December 2020 in all regions.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420182


17 Kasım 2021, Çarşamba, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020
This report describes updated interim vaccine allocation recommendations made by the Advisory Committee on Immunization Practices on December 20, 2020.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=415219


17 Kasım 2021, Çarşamba, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020
This report describes the interim recommendation made by the Advisory Committee on Immunization Practices on December 12, 2020, for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=414100